According to a recent study published in the American Journal of Cardiology, treatment of CAD appears to be shifting away from the inpatient setting.
Inpatient use of less-invasive revascularization treatments such as balloon angioplasty and stents administered via cardiac catheterization have contributed in part to a decline in hospitalization rates for coronary artery disease (CAD). According to a recent study published in the American Journal of Cardiology, treatment of CAD appears to be shifting away from the inpatient setting. U.S. hospitalization rates for heart attacks (acute myocardial infarctions) declined 10.6% from 2002 to 2005, possibly due to broader use of preventive treatments such as statin drugs and aspirin, as well as declines in risk factors like smoking. Researchers found that hospitalizations for acute myocardial infarction decreased steadily from 661,000 in 2002 to 591,000 in 2005a decline from 309 to 266 per 100,000 persons. Hospitalization rates for coronary revascularization declined from 382 to 358 per 100,000 persons from 2002 to 2005. This was due in part to a decrease in coronary artery bypass surgeries from 258,000 to 209,000 per year. Balloon angioplasty and stent implementations increased from 564,000 to 592,000 during that same period.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.